Likewise, mutants of pQE30/ PFGRX C32S/C88S were generated with the primers listed in Supplementary Table 10
These people may see confusion, changes in behaviour, slurred speech, clumsy movements, blurry or double vision, loss of consciousness, seizures, coma, and even death
Here are a few symptoms worth flagging to your GP, AF nurse, or cardiologist: New or worsening palpitations, especially if episodes feel longer or more frequent than usual A faster-than-usual resting heart rate, if you check it Light-headedness or dizziness, especially when standing up Increased breathlessness on exertion compared with your normal baseline An AF episode thats harder to settle than usual or doesnt respond to your usual rescue plan None of these is an emergency on its own, unless symptoms are severe
Early-phase clinical research on the cagrilintidesemaglutide combination has reported substantially greater reductions in body weight than either peptide alone, generating significant interest in the dual-pathway approach as a research model for obesity, type 2 diabetes, and related metabolic conditions
